KLK3 and prostate carcinoma: Moreover, the Prostate Cancer Research International AS (PRIAS) study also showed that AS is a safe option for men with low-risk prostate cancer (considered as GS ≤ 6, prostate-specific antigen (PSA) ≤10 ng/ml, and clinical stage not higher than T2c) [8].